Objectives To evaluate the impact and cost-effectiveness of introducing universal human
papillomavirus (HPV) vaccination into the National Immunization Program (NIP) in Brazil …

We use an empirically calibrated model to estimate the cost-effectiveness of cervical cancer
prevention in Brazil, a country with a high cervical cancer burden. Assuming 70% coverage …

Objective To assess the cost-utility of the human papillomavirus (HPV) vaccination on the
prevention of cervical cancer in the Brazilian Amazon region. Methods A Markov cohort …

Background Cervical cancer is a major public health problem in Latin America. Cost-
effectiveness studies help stakeholders with decisions regarding human papillomavirus …

We examined the cost-effectiveness of the quadrivalent HPV vaccine for the pre-adolescent
female population of Brazil. Using demographic, epidemiological and cancer data, we …

Background Cervical cancer is the leading cause of cancer deaths in Honduras. With the
availability of a vaccine to prevent human papillomavirus (HPV), the causative agent for …

Background Human papillomavirus (HPV) infection has been shown to be a major risk factor
for cervical cancer. Vaccines against HPV-16 and HPV-18 are highly effective in preventing …

OBJECTIVE: To estimate the benefits, cost-effectiveness (ie, value for money), and required
financial costs (eg, affordability) of adding human papillomavirus (HPV) vaccination to Peru's …

In Brazil, almost 16,000 new cases of cervical cancer (CC), the type of neoplasia that claims
the more lives of young women than any other, are expected in 2014. Although the vaccine …

Background: With promising efficacy results from randomized control trials of human
papillomavirus (HPV) vaccines and the availability of new screening paradigms …